{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T02:46:07Z","timestamp":1768617967899,"version":"3.49.0"},"reference-count":25,"publisher":"Informa UK Limited","issue":"7-9","funder":[{"name":"Karkinos Healthcare Private Limited"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Pharmacogenomics"],"published-print":{"date-parts":[[2025,6,13]]},"DOI":"10.1080\/14622416.2025.2547563","type":"journal-article","created":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T15:03:01Z","timestamp":1755183781000},"page":"231-236","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":2,"title":["Opportunistic analysis of clinically actionable DPYD gene variants in a germline testing cohort in India"],"prefix":"10.1080","volume":"26","author":[{"given":"Rajdeep","family":"Raha","sequence":"first","affiliation":[{"name":"Karkinos Healthcare Pvt. Ltd","place":["Bengaluru, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahul C.","family":"Bhoyar","sequence":"additional","affiliation":[{"name":"Karkinos Healthcare Pvt. Ltd","place":["Navi Mumbai, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ranendra Pratap","family":"Biswal","sequence":"additional","affiliation":[{"name":"Karkinos Healthcare Pvt. Ltd","place":["Navi Mumbai, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radhika","family":"Venkatakrishnan","sequence":"additional","affiliation":[{"name":"Karkinos Healthcare Pvt. Ltd","place":["Navi Mumbai, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prashant","family":"Rai","sequence":"additional","affiliation":[{"name":"Karkinos Healthcare Pvt. Ltd","place":["Navi Mumbai, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eshaa","family":"Umashankar","sequence":"additional","affiliation":[{"name":"Karkinos Healthcare Pvt. Ltd","place":["Navi Mumbai, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pooja Mahesh","family":"Kulkarni","sequence":"additional","affiliation":[{"name":"Karkinos Healthcare Pvt. Ltd","place":["Navi Mumbai, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sridhar","family":"Sivasubbu","sequence":"additional","affiliation":[{"name":"Karkinos Healthcare Pvt. Ltd","place":["Navi Mumbai, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinod","family":"Scaria","sequence":"additional","affiliation":[{"name":"Karkinos Healthcare Pvt. Ltd","place":["Bengaluru, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bani","family":"Jolly","sequence":"additional","affiliation":[{"name":"Karkinos Healthcare Pvt. Ltd","place":["Bengaluru, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2025,8,14]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1074"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.7-4-288"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1989.7.12.1769"},{"key":"e_1_3_5_6_1","article-title":"Toxicity of 5-fluorouracil","volume":"13","author":"Macdonald JS","year":"1999","unstructured":"Macdonald JS. Toxicity of 5-fluorouracil. Oncol (Williston Park, NY). 1999;13. Available https:\/\/pubmed.ncbi.nlm.nih.gov\/10442356\/","journal-title":"Oncol (Williston Park, NY)"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2008.03106.x"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0959-8049(99)00211-7"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118830"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2015.11.008"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1200\/OP.20.00553"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1177\/1559325818803042"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e40808"},{"key":"e_1_3_5_14_1","unstructured":"Center for Drug Evaluation Research. Safety announcement: fDA highlights importance of DPD deficiency discussions with patients prior to capecitabine or 5FU treatment. In: U.S. Food and Drug Administration [FDA] [Internet]; 2025 Jan 24 [cited 2025 Apr 17]. Available from: https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/safety-announcement-fda-highlights-importance-dpd-deficiency-discussions-patients-prior-capecitabine"},{"key":"e_1_3_5_15_1","unstructured":"Ema recommendations on dpd testing prior to treatment with fluorouracil capecitabine tegafur and flucytosine. European Medicines Agency (EMA) [Internet]. [cited 2025 Apr 17]. Available from: https:\/\/www.ema.europa.eu\/en\/news\/ema-recommendations-dpd-testing-prior-treatment-fluorouracil-capecitabine-tegafur-and-flucytosine"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2023.101197"},{"key":"e_1_3_5_17_1","unstructured":"Treatment by cancer type. In: NCCN [Internet]. [cited 2025 Apr 17]. Available from: https:\/\/www.nccn.org\/guidelines\/category_1"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs-2017-0101"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/cts.13153"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2024.103482"},{"key":"e_1_3_5_21_1","unstructured":"CPIC\u00ae Guideline for Fluoropyrimidines and DPYD. [cited 2025 Apr 17]. Available from: https:\/\/cpicpgx.org\/guidelines\/guideline-for-fluoropyrimidines-and-dpyd\/"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06045-0"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature15393"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv1189"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv1222"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2015.30"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/cts.13699"}],"container-title":["Pharmacogenomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14622416.2025.2547563","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T12:53:44Z","timestamp":1757595224000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14622416.2025.2547563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,13]]},"references-count":25,"journal-issue":{"issue":"7-9","published-print":{"date-parts":[[2025,6,13]]}},"alternative-id":["10.1080\/14622416.2025.2547563"],"URL":"https:\/\/doi.org\/10.1080\/14622416.2025.2547563","relation":{},"ISSN":["1462-2416","1744-8042"],"issn-type":[{"value":"1462-2416","type":"print"},{"value":"1744-8042","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,13]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ipgs20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ipgs20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-05-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}